Cognita Labs, founded in 2013 and headquartered in Santa Ana, California, is a medical device company dedicated to innovating pulmonary diagnosis and management. The company's core mission is to simplify pulmonary care through advanced medical devices. Cognita Labs focuses on addressing the global epidemic of chronic respiratory diseases, including Chronic Obstructive Pulmonary Diseases (COPD) and Obstructive Airways Diseases (OAD) like asthma. Their products aim to improve the quality of life for individuals affected by these conditions.
Notable affiliated people and investors include experts in the fields of pulmonology and medical technology. Cognita Labs has achieved significant milestones in developing user-friendly and effective diagnostic tools for respiratory care. Their innovations have had a substantial impact on the healthcare industry by providing accessible solutions for managing chronic respiratory conditions, ultimately contributing to better patient outcomes and reduced healthcare costs.
